Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

After tense standoff, AstraZeneca and Daiichi's Enhertu turned away by NICE on pricing grounds
Fierce Pharma
Monday, July 29, 2024 - 10:51am
tags:
AstraZeneca, Daiichi Sankyo, Enhertu, NICE, UK, HER2-low breast cancer
FDA places vTv's lead diabetes drug on hold over chromatographic signal
Fierce Biotech
Monday, July 29, 2024 - 10:49am
tags:
vTv Therapeutics, clinical trials, FDA, cadisegliatin, chromatogaphic sigma;
Blood tests may have an edge spotting Alzheimer's
Axios
Monday, July 29, 2024 - 10:46am
tags:
Medtech, diagnostics, Alzheimer's disease
Prediction: This Will Be Pfizer's Next Big Move
Motley Fool
Monday, July 29, 2024 - 10:43am
tags:
Pfizer, M&A
FDA approves Guardant Health's blood-based cancer test
Reuters
Monday, July 29, 2024 - 10:41am
tags:
FDA, diagnostics, Guardant Health, colorectal cancer, Shield, Medtech
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff
BioSpace
Monday, July 29, 2024 - 10:31am
tags:
AbbVie, Europe, Skyrizi, ulcerative colitis
Sage’s recent trial failure adds pressure to its two-drug Biogen collab
Pharma Voice
Monday, July 29, 2024 - 10:29am
tags:
SAGE Therapeutics, Biogen, clinical trials, SAGE-324, essential tremor, Zurzuvae, postpartum depression
NewAmsterdam drug cuts cholesterol, but by less than expectations, in phase 3 test
Fierce Biotech
Monday, July 29, 2024 - 10:27am
tags:
NewAmsterdam Pharma, cholesterol, clinical trials, obicetrapib, HeFH
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fierce Pharma
Friday, July 26, 2024 - 11:15am
tags:
Eisai, Biogen, Leqembi, Europe
Eisai adopts Medidata’s AI-driven platform for clinical trials
Clinical Trials Arena
Friday, July 26, 2024 - 11:13am
tags:
Eisai, Medidata, clinical trials, artificial intelligence
Abbott recalls Freestyle Libre 3 sensors due to incorrect glucose readings
Medtech Dive
Friday, July 26, 2024 - 11:11am
tags:
Abbott Labs, Medtech, device recalls, CGMs, FreeStyle Libre 3
Cue Biopharma downsizes to focus on autoimmune pipeline
Clinical Trials Arena
Friday, July 26, 2024 - 11:09am
tags:
Cue Biopharma, autoimmune disease, layoffs
Calliditas' liver disease trial hits primary endpoint after sweeping changes to design
Fierce Biotech
Friday, July 26, 2024 - 11:08am
tags:
Calliditas, liver disease, primary biliary cholangitis, clinical trials, setanaxib
BMS Gets Q2 Beat, Raises Full-Year Guidance as Cost-Cutting Initiative Continues
BioSpace
Friday, July 26, 2024 - 11:06am
tags:
Bristol Myers Squibb, earnings
Big Pharma Appears to Be Unfazed by IRA Drug Price Negotiations
BioSpace
Friday, July 26, 2024 - 11:05am
tags:
Big Pharma, drug pricing, Inflation Reduction Act
Clinical trial diversity is a balancing act of time, quality, and money
Clinical Trials Arena
Friday, July 26, 2024 - 11:04am
tags:
clinical trials, clinical trial diversity, FDA
GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Friday, July 26, 2024 - 11:03am
tags:
obesity, weight loss, GLP-1 agonist, healthcare costs, Eli Lily, Novo Nordisk, Wegovy, Zepbound
Indivior reaches $86 million opioid settlement with US states
Reuters
Friday, July 26, 2024 - 11:01am
tags:
Indivior, legal, opioids, opioid crisis
Citius’ first FDA decision date is approaching — and its CEO has millions on the line
Pharma Voice
Friday, July 26, 2024 - 10:59am
tags:
Citius Pharmaceuticals, Lymphir, FDA, persistent or recurrent cutaneous T-cell lymphoma
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
BioPharma Dive
Thursday, July 25, 2024 - 10:05pm
tags:
Roche, obesity, Carmot Therapeutics, CT-388, CT-996

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.